ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3049

Prevalence of Doctor-Diagnosed Arthritis Among Adults with Clinically Measured Pre-Diabetes— United States, 2009–2014

Kamil E. Barbour1, Michael Boring1, Charles Hemlick2, Jennifer M. Hootman3, Louise Murphy1 and Giuseppina Imperatore4, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3Centers for Disease Control and Prevention, Kennesaw, GA, 4Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: ARHP V: Epidemiology and Public Health

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:   In the US, over 86 million adults have pre-diabetes; physical activity is recommended to reduce the high risk of developing diabetes.  Arthritis is a common comorbid condition among persons with diabetes that is associated with reduced physical activity, presumably because of joint pain and swelling.  Arthritis may have the same effect among adults with pre-diabetes, but population-based estimates of arthritis prevalence among adults with pre-diabetes are unknown.

Methods: We used the 2009-2014 National Health and Nutrition Examination Survey (NHANES) to estimate the prevalence of arthritis among adults with pre-diabetes, overall and by various sociodemographic characteristics, as well as those with diabetes or neither condition.  NHANES is a nationally representative sample of the US non-institutionalized adult population with both interview and examination components. We limited our sample to adults aged ≥20 years with a fasting plasma glucose (fpg) measurement; unweighted sample sizes were 2,787 in 2009-2010; 2,471 in 2011-2012, and 2,574 in 2013-2014. Pre-diabetes was defined as glycated hemoglobin A1c (HbA1c) level of 5.7% to <6.5%, or a fasting plasma glucose (fpg) level of 100-125 mg/dL. Diabetes was defined as an HbA1c level of ≥ 6.5%, or fpg level of ≥ 126 mg/dL or a “yes” response to the questions “other than during pregnancy has a doctor or other health professional ever told you that have diabetes or sugar diabetes?” Arthritis was defined as a "yes" response to the questions "Has a doctor or other health professional ever told you that have arthritis?" For comparisons, estimates were age-standardized to the projected 2000 U.S. population; and pairwise comparisons were evaluated using a t-test with a Bonferroni-Holm correction for multiple comparisons.

Results: During 2009-2014, the prevalence (number) of adults with arthritis among those with pre-diabetes was 30% (27.9 million). The age-standardized prevalence of arthritis among adults with pre-diabetes (25.5%; 95% CI: 23.5-27.7%) was significantly (p-value=0.022) higher when compared with adults without diabetes (21.6%; 95% CI: 19.2-24.3%), but similar (p-value=0.182) to those with diabetes (28.6%; 95% CI: 24.8-32.7%)  (Figure). Among adults with pre-diabetes, older adults (age ≥ 65 years), women, and those with <college degree had the highest age-standardized prevalence of arthritis.   

Conclusion: Nearly 28 million adults in the US have pre-diabetes and arthritis, which may impact the physical activity recommended to prevent diabetes. Health care and public health professionals can address arthritis-specific barriers to physically activity among adults with pre-diabetes by promoting evidence-based physical activity, including programs such as EnhanceFitness and Walk with Ease, that reduce joint pain, which in turn may increase physical activity and reduce progression to diabetes.     

 

 


Disclosure: K. E. Barbour, None; M. Boring, None; C. Hemlick, None; J. M. Hootman, None; L. Murphy, None; G. Imperatore, None.

To cite this abstract in AMA style:

Barbour KE, Boring M, Hemlick C, Hootman JM, Murphy L, Imperatore G. Prevalence of Doctor-Diagnosed Arthritis Among Adults with Clinically Measured Pre-Diabetes— United States, 2009–2014 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-doctor-diagnosed-arthritis-among-adults-with-clinically-measured-pre-diabetes-united-states-2009-2014/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-doctor-diagnosed-arthritis-among-adults-with-clinically-measured-pre-diabetes-united-states-2009-2014/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology